NIH-funded research NIH-funded research

Investigating sleep and temperature disturbances as risk factors for Alzheimer's in individuals with Down syndrome.

Official title: Sleep and Temperature Disturbance as risk factors for Alzheimer's Disease in Down Syndrome: a Longitudinal Study

Funded at New York University School of Medicine · NIH-10591135 · Data updated 2026-11-12

This study is looking at how problems with sleep and body temperature might increase the risk of Alzheimer's Disease in people with Down syndrome, and it aims to find ways to improve their health by focusing on things like sleep apnea and sleep patterns.

More s Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2026
Funding year2023
Award (this year)$1,871,190
NIH project number1RF1AG080769-01
Project IDNIH-10591135 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older with Down syndrome who are at risk for Alzheimer's Disease.

Less likely to help

Patients without Down syndrome or those who are not at risk for Alzheimer's Disease may not benefit from this research.

What this research studies

This research focuses on understanding how sleep and body temperature disturbances may contribute to the risk of developing Alzheimer's Disease in individuals with Down syndrome. By examining a cohort of individuals with Down syndrome, the study aims to identify specific modifiable factors, such as obstructive sleep apnea and circadian rhythm disruptions, that could influence the onset of Alzheimer's. The research will utilize clinical assessments and biomarker analysis to track changes over time, providing insights into how these factors may be addressed to improve health outcomes.

Why it matters

Potential benefit: If successful, this research could lead to targeted interventions that reduce the risk of Alzheimer's Disease in individuals with Down syndrome.

How similar studies have gone: Previous research has shown promising results in identifying modifiable risk factors for Alzheimer's Disease, suggesting that this approach may yield valuable insights.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Blessing, Esther Marian — New York University School of Medicine
  • Study coordinator: Blessing, Esther Marian

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.